BrainStorm Cell Therapeutics
BCLI
#10710
Rank
NZ$18.64 M
Marketcap
NZ$1.69
Share price
6.52%
Change (1 day)
52.54%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2026 (TTM): -NZ$16.3 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$17.78 Million, an increase over its 2024 earnings that were of -NZ$20.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$16.3 Million-8.31%
2025 -NZ$17.78 Million-11.32%
2024 -NZ$20.05 Million-32.39%
2023 -NZ$29.65 Million-29.18%
2022 -NZ$41.87 Million-0.74%
2021 -NZ$42.18 Million-23.12%
2020 -NZ$54.86 Million36.8%
2019 -NZ$40.1 Million66.71%
2018 -NZ$24.06 Million181.66%
2017 -NZ$8.54 Million-0.6%
2016 -NZ$8.6 Million-41.31%
2015 -NZ$14.64 Million-8.22%
2014 -NZ$15.95 Million89.74%
2013 -NZ$8.41 Million42.27%
2012 -NZ$5.91 Million-12.45%
2011 -NZ$6.75 Million63.04%
2010 -NZ$4.14 Million35.52%
2009 -NZ$3.06 Million-48.99%
2008 -NZ$5.99 Million-44.39%
2007 -NZ$10.77 Million
2005 -NZ$5.58 Million-91.44%
2004 -NZ$65.15 Million94007.62%
2003 -NZ$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
NZ$2.79 B-17,059.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$18.49 B-112,200.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-NZ$1.37 Billion 8,160.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-NZ$1.44 Billion 8,568.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.20 B-1,350.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-NZ$0.45 Billion 2,569.69%๐Ÿ‡บ๐Ÿ‡ธ USA